|
| |
ABOUT RADIUS
Background
Radius Ventures is a venture capital firm focused on leading-edge health and life sciences companies. Formed in 1997, Radius searches for the winners of tomorrow - entrepreneurs whose ideas and talents qualify them to pursue large market opportunities successfully. We seek opportunities across a broad spectrum including biotechnology and pharmaceuticals, medical devices, services and healthcare/life sciences information technology. Our goal is to identify companies on the cusp of major value creation where we can envision liquidity over a three to five year time frame.
We invest much more than money in our companies. Our distinctive approach blends significant
financial investment with unique access to world-class intellectual capital. Our goal is to fuel
the rapid growth of our portfolio companies and drive substantial value creation. As collaborative
partners, we pledge our full support throughout the ups and downs of a company's growth.
Radius helps entrepreneurs accelerate their business development,
compress timelines to critical milestones, build high-caliber management teams, and reach
a higher valuation plateau for their next round of financing or exit. Because we
invest early in a company's development, we can make a substantial
difference in its trajectory of growth, risk profile and pace of value creation.
At Radius, the most rewarding and satisfying part of our work is seeing each of
our portfolio companies succeed to its fullest potential.
Radius currently manages three funds with total committed capital of approximately $180 million.
Generally, we invest up to $10 million over initial and subsequent
financing rounds, as a lead or syndicate investor.
The Health and Life Sciences Industry
Opportunities abound in the health and life sciences industry. Sweeping
structural changes and scientific breakthroughs are driving demand for new
products and services that enhance patient care
and improve operational and administrative efficiencies.
Advanced technologies and the genomics revolution are driving fundamental
change in life science research, promising to accelerate the pace and improve
the efficiency of drug discovery and development. Novel therapeutics, diagnostics
and minimally invasive interventional approaches are creating new paradigms
for successful diagnosis, treatment and prevention of disease. Emerging
information technology platforms are enabling new models for more efficient,
effective and safer healthcare delivery. Entrepreneurs who can effectively
build companies that capitalize on these powerful trends face a bright future. |
| |
| |
|
|
E-mail:
Investor Login: click here
|
|
Radius Ventures, LLC
400 Madison Avenue
8th Floor
New York, NY 10017
Tel: 212-897-7778
Fax: 212-397-2656
|
| |
|
|
|